7 Indicators Pointing Towards Life Sciences Growth In 2024

Here is a list of 7 key indicators when it comes to the progress in the life sciences sector in 2024 which itself suggests of rapid advancements taking place.

Pushing Quality By Design, A Standard In Drug Development

To help quality by design- QbD to become an ideal standard in drug development, pharma must pursue innovative plans that go on to offer high quality levels.

Critical Chronic Issues Adapt Well To Synthetic Antibiotics

The University of Liverpool researchers have come up with a new synthetic antibiotic which has shown more reliability against certain superbugs such as MRSA.

2024 May Have Regulations Change In The Biopharma Backdrop

With the new FDA requirements and also the IRA creating intricacies in 2024, the biopharma is all set to navigate those changes with making certain shifts.

US, UK Regulatory Changes Lined Up In 2024 For Life Sciences

The life sciences sector in the US & the UK is all set to undergo major regulatory changes in 2024 with pharma firms urged to be ready for legal alterations.